Ipsen's ambition is to become a global leader in the treatment of
targeted debilitating diseases.
Not exact matches
«Previous bacterial infection increases risk of newly - diagnosed Sjögren's syndrome: Identifying trigger will hopefully help future development of
targeted therapy for patients suffering from this
debilitating disease.»
In the end, the identification of microbial species or metabolites that are altered in Parkinson's
disease may serve as
disease biomarkers or even drug
targets, and interventions that correct microbial imbalances may provide safe and effective treatments to slow or halt the progression of often
debilitating motor symptoms.
By pairing a receptor that
targets neurons with a molecule that degrades the main component of Alzheimer's plaques, the biologists were able to substantially dissolve these plaques in mice brains and human brain tissue, offering a potential mechanism for treating the
debilitating disease, as well as other conditions that involve either the brain or the eyes.
A new drug
targeting the root of this
debilitating degenerative
disease could be the vanguard of a novel class of treatments
«This study illustrates the potential of gaining fundamental insights into brain function while helping patients with
debilitating diseases, and provides us with a powerful way of selecting
targets based on their connectivity to other regions that can be widely applied to help guide brain stimulation therapy across multiple neurological and psychiatric disorders.»
Results of the study, published today (19 March) in Nature Genetics, could open the door to new
targeted therapies for this
debilitating disease in the future.
Adult stem cell therapy is a promising new approach to addressing the
disease cycle and resulting symptoms seen in MS. Making use of the powerful healing mechanisms of stem cells present in your adipose (fat) tissue, Okyanos Cell Therapy presents the opportunity to address
debilitating MS symptoms while
targeting nerve cell repair.
«It is our hope that emerging technologies and future studies will expand on our work, and ultimately lead to safe,
targeted, and cost - effective therapies that markedly improve visual outcomes and quality of life for patients suffering from these
debilitating eye
diseases.»